PUBLICATIONS DATABASE
Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease
International Journal of Chronic Obstructive Pulmonary Disease
7 September 2014
Claire Brockwell, Sundari Ampikaipakan, Darren W Sexton, David Price, Daryl Freeman, Mike Thomas, Muzammil Ali, Andrew Wilson
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
International Journal of Chronic Obstructive Pulmonary Disease
27 August 2014
David Price, Daniel West, Guy Brusselle, Kevin Gruffyd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart, Katsiaryna Bichel
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study
BMC Pulmonary Medicine
16 January 2014
Henry Chrystyn, David Price, Mathieu Molimard, John Haughney, Sinthia Bosnic-Anticevich, Federico Lavorini, John Efthimiou, Dawn Shan, Erika Sims, Annie Burden, Catherine Hutton, Nicolas Roche
Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
Clinical and Translational Allergy
7 November 2013
David Price, Dermot Ryan, Annie Burden, Julie von Ziegenweidti, Shuna Gould, Daryl Freeman, Kevin Gruffyd-Jones, Anne Copland, Clifford Godley, Alison Chisholm, Mike Thomas
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients
Primary Care Respiratory Journal
2 November 2013
David Price, Iain Small, John Haughney, Dermot Ryan, Kevin Gruffyd-Jones, Federico Lavorini, Tim Harris, Annie Burden, Jeremy Brockman, Christine King, Alberto Papi
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone
Journal of Allergy and Clinical Immunology
15 April 2013
Gene Colice, Richard J Martin, Elliot Israel, Nicolas Roche, Neil Barnes, Annie Burden, Peter Polos, Paul M Dorinsky, Elizabeth V Hillyer, Amanda Lee, Alison Chisholm, Julie von Ziegenweidti, Francesca Barion, David Price
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
The Lancet Respiratory Medicine
13 February 2013
Rupert Jones, David Price, Dermot Ryan, Erika Sims, Julie von Ziegenweidti, Laurence Mascarenhas, Annie Burden, David Halpin, Robert Winter, Sue Hill, Matt Kearney, Kevin Holton, Anne Moger, Daryl Freeman, Alison Chisholm, Eric Bateman, The Respiratory Effectiveness Group
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial
PharmacoEconomics
23 September 2012
Edward C.F. Wilson, Erika Sims, Stanley D. Musgrave, Lee Shepstone, Annie Blyth, Jamie Murdoch, H. Miranda Mugford, Elizabeth F Juniper, Jon G. Ayres, Stephanie Wolfe, Daryl Freeman, Richard F.T. Gilbert, Ian Harvey, Elizabeth V Hillyer, David Price
Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care
Allergy, Asthma & Immunology Research
6 April 2012
David Price, Henry Chrystyn, Alan Kaplan, John Haughney, Miguel Román Rodríguez, Annie Burden, Alison Chisholm, Elizabeth V Hillyer, Julie von Ziegenweidti, Muzammil Ali
A survey on the management of acute rhinosinusitis among Asian physicians
Rhinology
1 August 2011
De-Yun Wang, Retno S. Wardani, Kuljit Singh, Sanguansak Thanaviratananich, Gil Vicente, Geng Xu, Mohammad Rashid Zia, Achal Gulati, Sheen-Yie Fang, Li Shi, Yiong-Huak Chan, David Price, Valerie J. Lund, Joaquim Mullol, Wytske Fokkens
Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study
Clinical and Experimental Allergy
14 July 2011
Barnes, David Price, Gene Colice, Alison Chisholm, P. Dorinsky, Elizabeth V Hillyer, Annie Burden, Amanda Lee, Richard J Martin, Nicolas Roche, J. von Ziegenweidt, Elliot Israel
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial
Pharmacoeconomics
14 July 2011
Edward C.F. Wilson, David Price, Stanley D. Musgrave, Erika Sims, Lee Shepstone, Jamie Murdoch, H. Miranda Mugford, Annie Blyth, Elizabeth F Juniper, Jon G. Ayres, Stephanie Wolfe, Daryl Freeman, Richard F.T. Gilbert, Elizabeth V Hillyer, Ian Harvey